News from the economy, politics and the financial markets
In this section of our news section we provide you with editorial content from leading publishers.
Latest news
This is Jefferies top 2026 real estate play on an aging population. It also pays a solid dividend
Investors should stick with durable earnings growth themes for real estate stocks, including the aging population. This senior housing provider is its top pick.
Santa Claus rally: What is it and will it occur this year?
As the new year draws closer, eyes are turning to Wall Street to see whether it will pull off the coveted Santa Claus rally.
Stocks making the biggest moves midday: Lamb Weston, KB Home, Carnival, Oracle, CoreWeave & more
Check out some of the stocks making the biggest moves in midday trading.
Trump's name added to Kennedy Center building a day after board votes to rename DC theater
President Kennedy's niece, Maria Shriver, said it is "beyond comprehension that this sitting president has sought to rename this great memorial."
Morgan Stanley seen as front-runner for SpaceX IPO, sources say
Morgan Stanley is emerging as a leading contender for a key role in SpaceX's blockbuster initial public offering.
The bottom in Oracle may be in. This options trade lets you ride the gains while limiting risk
It may be time to own this essential AI product and service behemoth.
Visa, Mastercard to pay $167.5 million in ATM user fee settlement
Visa and Mastercard have agreed to pay a combined $167.5 million to settle a class action lawsuit accusing them of conspiring to keep ATM access fees high.
Jim Cramer says buy Nike's steep post-earnings fall. Here's why
The big post-earnings drop in Nike shares is a big opportunity.
Classic-car market poised for strong 2026, says Hagerty CEO
A new generation of collectors are more comfortable buying online, with online classic-car sales surging 12% this year to $2.5 billion, according to Hagerty.
Jeffrey Epstein: Dems say DOJ breaking law with plan to release files over time
President Donald Trump signed the Epstein Files Transparency Act in November.
Trump suspends U.S. green card lottery after Brown University shooting
USCIS is pausing the Diversity Immigrant Visa Program after the fatal Brown University shooting last week, Homeland Security Secretary Kristi Noem said.
Claire's new owner Ames Watson feuds with Asia-based suppliers over millions in unpaid debt
The dispute with suppliers could complicate new owner Ames Watson's efforts to turn around the struggling mall retailer.
November home sales struggle as supply stalls
Existing home sales edged slightly higher as prices continued to rise and supply dropped. The higher end of the market is performing better.
'Avatar: Fire and Ash' snares $12 million in Thursday previews
Disney and James Cameron's "Avatar: Fire and Ash" hit theaters Thursday, snapping up $12 million in early preview screenings domestically.
Pro Talks: Jason Snipe on his investing game plan for 2026
Jason Snipe, founder & chief investment officer at Odyssey Capital Advisors, sits down with CNBC's Dominic Chu to discuss how investors should prepare for the trading year ahead. He talks the future of the AI trade, how the economy could shape markets and more. Plus, he answers questions from CNBC Pro subscribers.
Waller had a 'strong interview' for Fed chair with Trump as president appears to turn focus to job market
The positive description of the Waller interview by officials was not necessarily an indication that he was a favorite candidate for the job.
NY Fed President Williams says some 'technical factors' distorted November's CPI reading downward
Williams said "technical factors" likely distorted November's inflation data, pushing the headline reading lower than it otherwise would have been.
UnitedHealth Group commits to improvements after independent audit, patient backlash
The company said it has adopted 23 ongoing "action plans" to track and implement recommended improvements, all of which will be completed by the end of March.
BioMarin to acquire Amicus Therapeutics for $4.8 billion in rare disease bet
BioMarin Pharmaceutical said on Friday it would acquire Amicus Therapeutics for about $4.8 billion, expanding its presence in rare metabolic diseases.
Trump's 'Gold Card' relies on legal loophole to help wealthy foreigners get U.S. visa
In exchange for $1 million and a $15,000 processing fee, "Gold Card" applicants will get full-time residency in the U.S., the program's website says.
Showing 1 to 20 of 4035 entries
